Cardiotoxicity of interferon: A review of 44 cases

Chest

Volumn 99, Issue 3, 1991, Pages 557-561

  Sonnenblick, M ^a   Rosin, A ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; DOXORUBICIN;

ADULT; AGED; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL ARTICLE; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 0026026353     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.99.3.557     Document Type: Article

References (35)

1. Kirkwood J Ernstoff MS. Interferons in the treatment of human cancer J Clin Oncol 2 1984 336 352
2. Dickson D. Death halts interferon trials in France Science 218 1982 772
3. Oldham RR. Toxic effects of interferon Science 219 1983 902
4. Sarna G Figlin R Callaghan M. Alpha (human leukocyte) interferon as treatment for non-small cell carcinoma of the lung: a phase H trial J Biol Response Mod 2 1983 343 347
5. Budd CT Bukowski RM Miketo L Yen-Lieberman B Proffitt MR. Phase I trial of ultrapure human leukocyte interferon in human malignancy Cancer Chemother Pharmacol 12 1984 39 42
6. Foon KA Sherwin SA Abrams PG Longo DL Fer MF Stevenson HC Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon N Engl J Med 311 1984 1148 1152
7. Kirkwood J Ernstoff MS Davis CA Reiss M Ferraresi R Rudnick SA. Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers Ann Intern Med 103 1985 32 36
8. Grunberg SM Kempf RA Itri LM Venturi CL Boswell WD Mitchell MS. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma Cancer Treat Rep 69 1985 1031 1032
9. Cooper MR Fefer A Thompson J Case DC Kempf R Sacher R Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial Cancer Treat Rep 70 1986 473 476
10. Vadhan-Raj S Al-Katib A Bhalla R Pelus L Nathan CF Sherwin SA Phase I trial of recombinant interferon gamma in cancer patients J Clin Oncol 4 1986 137 146
11. Martino S Ratanatharathorn V Karanes C Samal BA Ho-Sohn Y Rudnick SA. Reversible arrhythmias observed in patients treated with recombinant alpha-2 interferon J Cancer Res Clin Oncol 113 1987 376 378
12. Cohen MC Huberman MS Nesto RW. Recombinant alpha-2 interferon related cardiomyopathy Am J Med 85 1988 549 550
13. Deyton LR Walker RE Kovacs JA Herpin B Parker M Masur H Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma N Engl J Med 321 1989 1246 1249
14. Sonnenblick M Rosenmann D Rosin A. Reversible interferon induced cardiomyopathy Br Med J 300 1990 1174 1175
15. Ernstoff MS Trautman T Davis CA Reich SD Witman P Balse J A randomised phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma J Clin Oncol 5 1987 1804 1810
16. Brown TD Koeller J Beougher K Golando J Bonnem EM Spiegel RJ A phase I clinical trial of recombinant DNA gamma interferon J Clin Oncol 5 1987 790 798
17. Friess GG Brown TD Wrenn RC. Cardiovascular rhythm effects of gamma recombinant DNA interferon Invest New Drugs 7 1989 275 280
18. Sherwin SA Knost JA Fein S Abrams PG Foon KA Ochs JJ A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients JAMA 248 1982 2461 2466
19. Rohatiner AZ Ralkwill FR Griffin DB Malpas JS Lister TA. A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion Cancer Chemother Pharmacol 9 1982 97 102
20. Smith D Wagstaff J Thatcher N Scarffe H. A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion Cancer Chemother Pharmacol 20 1987 327 331
21. Muss HB Richards F Homesly HD Spurr CL Rudnick SA Stuart JJ. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy Am J Clin Oncol 8 1985 97 107
22. Janssen JT Ludwig H Scheithauer W De Pauw BE Keyser A Van Tol R Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies Oncology 42 1985 3 6
23. Sarna G Figlin R Bryson Y Garratty E Myers L Le Fevre C Human alpha-lymphoblastoid interferon: a phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs) Am J Clin Oncol. 8 1985 406 412
24. Wagstaff J Chadwick G Howell A Thatcher N Scarffe JH Crowther D. A phase I toxicity study of human rDNA interferon in patients with solid tumors Cancer Chemother Pharmacol 13 1984 100 105
25. Edelstien MB Schellekens H Laurent T Gauci L. A phase I clinical tolerance study of rDNA alpha 2 human interferon in patients with non-reticuloendothelial system malignancies Eur J Cancer Clin Oncol 19 1983 891 894
26. Garnick MB Reich SD Maxwell B Coval-Goldsmith S Richie JP Rudnick SA. Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma J Urol 139 1988 251 255
27. Perez R Lipton A Harvey HA Simmonds MA Romano PJ Imboden SL A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy J Biol Response Mod 7 1988 309 317
28. Kurzrock R Quesada JR Talpaz M Hersh EM Reuben JM Sherwin SA Phase I study of multiple dose intramuscularly administered recombinant gamma interferon J Clin Oncol 4 1986 1101 1109
29. Vadhan-Raj S Nathan CF Sherwin SA Oettgen HF Krown SE. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion Cancer Treat Rep 70 1986 609 614
30. Foon KA Sherwin SA Abrams PG Stevenson HC Holmes P Maluish AE. A phase I trial of recombinant gamma interferon in patients with cancer Cancer Immunol Immunother 20 1985 193 197
31. Sarna G Pertcheck M Figlin R Ardalan B. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer Cancer Treat Rep 70 1986 1365 1372
32. Borden EC Hawkins MJ Sielaff KM Storer BM Schiesel JD Smalley RV. Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial J Interferon Res 8 1988 357 366
33. Borden EC. Effects of interferon in neoplastic diseases of man Pharmacol Ther 37 1988 213 229
34. Lampidis TJ Brouty-Boye D. Interferon inhibits cardiac cell function in vitro (41043) Proc Soc Exp Biol Med 166 1981 181 185
35. Bialock JE Stanton JD. Common pathways of interferon and hormonal action Nature 283 1980 406 408